Your browser doesn't support javascript.
loading
Sphingosine kinase 1 promotes liver fibrosis by preventing miR-19b-3p-mediated inhibition of CCR2.
Lan, Tian; Li, Changzheng; Yang, Guizhi; Sun, Yue; Zhuang, Lihang; Ou, Yitao; Li, Hui; Wang, Genshu; Kisseleva, Tatiana; Brenner, David; Guo, Jiao.
  • Lan T; Guangdong Pharmaceutical University, Guangzhou, China.
  • Li C; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangzhou, China.
  • Yang G; Joint Laboratory of Guangdong, Hong Kong and Macao on Glycolipid Metabolic Diseases, Guangzhou, China.
  • Sun Y; Guangdong Pharmaceutical University, Guangzhou, China.
  • Zhuang L; Guangdong Pharmaceutical University, Guangzhou, China.
  • Ou Y; Guangdong Pharmaceutical University, Guangzhou, China.
  • Li H; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangzhou, China.
  • Wang G; Joint Laboratory of Guangdong, Hong Kong and Macao on Glycolipid Metabolic Diseases, Guangzhou, China.
  • Kisseleva T; Guangdong Pharmaceutical University, Guangzhou, China.
  • Brenner D; Guangdong Metabolic Disease Research Center of Integrated Chinese and Western Medicine, Guangzhou, China.
  • Guo J; Joint Laboratory of Guangdong, Hong Kong and Macao on Glycolipid Metabolic Diseases, Guangzhou, China.
Hepatology ; 68(3): 1070-1086, 2018 09.
Article en En | MEDLINE | ID: mdl-29572892

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfotransferasas (Aceptor de Grupo Alcohol) / MicroARNs / Receptores CCR2 / Cirrosis Hepática Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fosfotransferasas (Aceptor de Grupo Alcohol) / MicroARNs / Receptores CCR2 / Cirrosis Hepática Límite: Animals / Humans Idioma: En Año: 2018 Tipo del documento: Article